ARTICLE | Clinical News
PolyTherics, Pro Bono Bio preclinical data
September 24, 2012 7:00 AM UTC
In dogs with hemophilia, subcutaneous long-acting pegylated Factor VIIa prolonged the amount of time free from bleeding risk by 72 hours vs. 0 hours for unmodified Factor VIIa. Additionally, IV long-a...